Exposure to combined treatment provoked a reduction of pro-survival ER chaperon BIP/Grp78 expression, the main activator of the UPR and a well-known facilitator of tumor cell evasion from chemotherapeutics. This evidence concerns the gene HSPA5 and neoplasm.